AB Science S.A. (0Q77.L)

EUR 0.87

(-6.75%)

Total Assets Summary of AB Science S.A.

  • AB Science S.A.'s latest annual total assets in 2023 was 25.49 Million EUR , up 6.95% from previous year.
  • AB Science S.A.'s latest quarterly total assets in 2024 Q2 was 22.98 Million EUR , down 0.0% from previous quarter.
  • AB Science S.A. reported annual total assets of 23.84 Million EUR in 2022, up 12.08% from previous year.
  • AB Science S.A. reported annual total assets of 21.27 Million EUR in 2021, down -28.35% from previous year.
  • AB Science S.A. reported quarterly total assets of 25.49 Million EUR for 2023 FY, up 6.95% from previous quarter.
  • AB Science S.A. reported quarterly total assets of 33.19 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of AB Science S.A. (2023 - 2009)

Historical Annual Total Assets of AB Science S.A. (2023 - 2009)

Year Total Assets Total Assets Growth
2023 25.49 Million EUR 6.95%
2022 23.84 Million EUR 12.08%
2021 21.27 Million EUR -28.35%
2020 29.68 Million EUR 67.35%
2019 17.74 Million EUR -21.12%
2018 22.49 Million EUR -55.55%
2017 50.6 Million EUR 33.12%
2016 38.01 Million EUR 16.67%
2015 32.57 Million EUR 4.16%
2014 31.27 Million EUR -28.32%
2013 43.63 Million EUR 45.53%
2012 29.98 Million EUR 1.76%
2011 29.46 Million EUR 0.22%
2010 29.39 Million EUR 108.7%
2009 14.08 Million EUR 0.0%

Peer Total Assets Comparison of AB Science S.A.

Name Total Assets Total Assets Difference
Boiron SA 590.2 Million EUR 95.68%
Laboratorios Farmaceuticos Rovi, S.A. 799.88 Million EUR 96.812%
Vetoquinol SA 692.23 Million EUR 96.316%
Valneva SE 469.39 Million EUR 94.568%
Nanobiotix S.A. 93.89 Million EUR 72.844%
PHAXIAM Therapeutics S.A. 51.3 Million EUR 50.301%
Vivoryon Therapeutics N.V. 30.82 Million EUR 17.289%
BioSenic S.A. 9.55 Million EUR -166.754%
ABIVAX Société Anonyme 327.06 Million EUR 92.204%
Formycon AG 890.36 Million EUR 97.136%